Saizo Fujmoto

6PUBLICATIONS
32CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 02, 2026
Clinical Impact of Gleason Pattern 5 on Doublet Versus Triplet Therapy in Metastatic Hormone-Sensitive Prostate Cancer.

|Jul 27, 2025
Prognostic Impact of Initial Prostate-Specific Antigen in Metastatic Hormone-Sensitive Prostate Cancer Patients With Extensive Bone Metastases Under Androgen Receptor Signaling Inhibitor.

Saizo Fujimoto, Tsuyoshi Morita, Yutaka Yamamoto

|Jan 31, 2025
Immunohistochemical Analysis of Androgen Receptor Expression Predicts the Prognosis of Metastatic Castration-Sensitive Prostate Cancer Patients Receiving Abiraterone Acetate.

Mitsuhisa Nishimoto, Marco A De Velasco, Yutaka Yamamoto

|Dec 04, 2024
Comparative analysis of gut microbiota in hormone-sensitive and castration-resistant prostate cancer in Japanese men.

Saizo Fujimoto, Koji Hatano, Eri Banno

|Aug 08, 2024
A cross-species analysis of fecal microbiomes in humans and mice reveals similarities and dissimilarities associated with prostate cancer risk.

Chisato Wakamori, Marco A De Velasco, Kazuko Sakai

|Aug 31, 2022
Sequential therapy with darolutamide in patients with non-metastatic castration-resistant prostate cancer resistant to enzalutamide or apalutamide.

Saizo Fujmoto, Kazutoshi Fujita, Mitsuhisa Nishimoto

Pageof 1

Frequent Collaborators

5 joint publications

Kazutoshi Fujita

4 joint publications

Hirotsugu Uemura

3 joint publications

Marco Antonio De Velasco

3 joint publications

Yutaka Yamamoto